Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Nature Communications
|
August 21, 2021
The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
Per Plenge, Dongxue Yang, Kristine Salomon, et al.
ACS Chemical Neuroscience
|
September 16, 2021
Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D<sub>3</sub> Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders
Alessandro Bonifazi, Amy H Newman, Thomas M Keck, et al.
The Journal of Biological Chemistry
|
November 8, 2005
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants
L Keith Henry, Julie R Field, Erika M Adkins, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 16, 2006
Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype
Cecile Martinat, Jean-Jacques Bacci, Thomas Leete, et al.
Neuron
|
April 21, 2019
Synaptic Vesicle Recycling Pathway Determines Neurotransmitter Content and Release Properties
Kätlin Silm, Jing Yang, Pamela F Marcott, et al.
Behavioural Pharmacology
|
May 14, 2010
Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats
Su-Min Li, Gregory T Collins, Noel M Paul, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 31, 2014
Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys
Susan E Martelle, Susan H Nader, Paul W Czoty, et al.
Pharmacology, Biochemistry, and Behavior
|
March 11, 2008
The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity
Panayotis K Thanos, Michael Michaelides, Christopher W Ho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 13, 2014
2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter
Takato Hiranita, Derek S Wilkinson, Weimin C Hong, et al.
Neuropharmacology
|
February 7, 2018
Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays
Hideaki Yano, Alessandro Bonifazi, Min Xu, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Nature Communications
|
August 21, 2021
The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
Per Plenge, Dongxue Yang, Kristine Salomon, et al.
ACS Chemical Neuroscience
|
September 16, 2021
Scaffold Hybridization Strategy Leads to the Discovery of Dopamine D<sub>3</sub> Receptor-Selective or Multitarget Bitopic Ligands Potentially Useful for Central Nervous System Disorders
Alessandro Bonifazi, Amy H Newman, Thomas M Keck, et al.
The Journal of Biological Chemistry
|
November 8, 2005
Tyr-95 and Ile-172 in transmembrane segments 1 and 3 of human serotonin transporters interact to establish high affinity recognition of antidepressants
L Keith Henry, Julie R Field, Erika M Adkins, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 16, 2006
Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype
Cecile Martinat, Jean-Jacques Bacci, Thomas Leete, et al.
Neuron
|
April 21, 2019
Synaptic Vesicle Recycling Pathway Determines Neurotransmitter Content and Release Properties
Kätlin Silm, Jing Yang, Pamela F Marcott, et al.
Behavioural Pharmacology
|
May 14, 2010
Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats
Su-Min Li, Gregory T Collins, Noel M Paul, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 31, 2014
Further characterization of quinpirole-elicited yawning as a model of dopamine D3 receptor activation in male and female monkeys
Susan E Martelle, Susan H Nader, Paul W Czoty, et al.
Pharmacology, Biochemistry, and Behavior
|
March 11, 2008
The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity
Panayotis K Thanos, Michael Michaelides, Christopher W Ho, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 13, 2014
2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter
Takato Hiranita, Derek S Wilkinson, Weimin C Hong, et al.
Neuropharmacology
|
February 7, 2018
Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays
Hideaki Yano, Alessandro Bonifazi, Min Xu, et al.
Page
of 8